GoodRx (NASDAQ:GDRX) Shares Gap Down – Should You Sell?

GoodRx Holdings, Inc. (NASDAQ:GDRX) gapped down prior to trading on Friday . The stock had previously closed at $4.95, but opened at $4.81. GoodRx shares last traded at $4.81, with a volume of 131,259 shares trading hands.

Wall Street Analyst Weigh In

Several equities research analysts have issued reports on the stock. Mizuho began coverage on shares of GoodRx in a report on Wednesday, December 4th. They issued a “neutral” rating and a $5.00 price target on the stock. Morgan Stanley cut their price target on GoodRx from $7.00 to $6.00 and set an “equal weight” rating for the company in a report on Tuesday, December 17th. Citigroup decreased their price objective on shares of GoodRx from $7.00 to $6.25 and set a “buy” rating on the stock in a report on Friday, January 10th. Barclays dropped their target price on shares of GoodRx from $10.00 to $6.00 and set an “overweight” rating for the company in a research note on Monday, November 11th. Finally, KeyCorp decreased their price target on shares of GoodRx from $7.00 to $6.00 and set an “overweight” rating on the stock in a research note on Wednesday, January 8th. Five investment analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $8.38.

GoodRx Stock Down 1.4 %

The company has a quick ratio of 5.48, a current ratio of 5.48 and a debt-to-equity ratio of 0.70. The firm has a 50 day simple moving average of $4.66 and a 200-day simple moving average of $6.26. The stock has a market cap of $1.86 billion, a P/E ratio of -161.70, a price-to-earnings-growth ratio of 2.45 and a beta of 1.27.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the stock. Rubric Capital Management LP raised its stake in GoodRx by 25.2% in the third quarter. Rubric Capital Management LP now owns 4,680,028 shares of the company’s stock valued at $32,479,000 after purchasing an additional 943,226 shares in the last quarter. Millennium Management LLC lifted its holdings in shares of GoodRx by 36.5% during the 2nd quarter. Millennium Management LLC now owns 4,121,939 shares of the company’s stock worth $32,151,000 after acquiring an additional 1,102,758 shares during the period. Point72 Asset Management L.P. acquired a new stake in shares of GoodRx during the 3rd quarter worth approximately $11,295,000. Geode Capital Management LLC increased its stake in GoodRx by 6.3% in the third quarter. Geode Capital Management LLC now owns 982,729 shares of the company’s stock valued at $6,823,000 after acquiring an additional 58,610 shares during the last quarter. Finally, Franklin Resources Inc. acquired a new position in shares of GoodRx during the 3rd quarter worth $5,675,000. 63.77% of the stock is owned by institutional investors.

About GoodRx

GoodRx Holdings, Inc, together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices.